Changeflow GovPing Healthcare & Life Sciences Light Adjustable Ophthalmic Devices Patent Appl...
Routine Notice Added Final

Light Adjustable Ophthalmic Devices Patent Application

Favicon for changeflow.com USPTO Patent Applications - Prosthetics (A61F)
Published
Detected
Email

Summary

The USPTO has published patent application US20260109796A1, filed October 16, 2025, covering reactive monomer compositions designed for use in light adjustable ophthalmic devices including intraocular lenses, contact lenses, and corneal inserts. The compositions form polymers with editable refractive indices that change upon exposure to specific light wavelengths through intramolecular cycloaddition reactions. When used in implantable ophthalmic devices, the compositions enable post-operative fine-tuning of device optics via light treatment after implantation and healing.

“When used in ophthalmic devices, the inventive compositions enable post-manufacturing and/or post-operative adjustments to the optics of the devices by spatially modifying the refractive index.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Prosthetics (A61F) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 206 changes logged to date.

What changed

The USPTO published patent application US20260109796A1 on April 23, 2026, covering compositions for light adjustable ophthalmic devices such as intraocular lenses, phakic intraocular lenses, contact lenses, orthokeratology lenses, and corneal inserts. The application claims reactive monomer mixtures that form polymers with editable refractive indices capable of being spatially modified through light irradiation, enabling post-manufacturing and post-operative adjustments to device optics.

Affected parties include manufacturers of ophthalmic devices seeking post-operative refractive correction capabilities, pharmaceutical companies involved in ocular implant technology, and medical device companies developing next-generation intraocular lenses. While this is a published patent application rather than a granted patent, it signals the technology space and potential future licensing or development opportunities in the light-adjustable lens sector. Parties monitoring this space should track the application through prosecution to identify potential freedom-to-operate considerations.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES

Application US20260109796A1 Kind: A1 Apr 23, 2026

Inventors

Shivkumar Mahadevan, Azaam Alli, Scott Joslin

Abstract

This invention is directed to compounds and compositions which are designed for use in light adjustable ophthalmic devices, such as intraocular implants, intraocular lenses, phakic intraocular lenses, contact lenses, orthokeratology lenses, rigid gas permeable lenses, corneal inlays, corneal outlays, or corneal inserts. The inventive compositions are produced from reactive monomer mixtures which when polymerized form polymers or polymeric networks having editable refractive indices. Such inventive compositions when exposed to light of certain wavelengths undergo intramolecular cycloaddition reactions thereby changing the refractive index in the irradiated regions. When used in ophthalmic devices, the inventive compositions enable post-manufacturing and/or post-operative adjustments to the optics of the devices by spatially modifying the refractive index. For example, the vision of a patient with an intraocular lens made of the inventive compositions can be fine-tuned after implantation and healing by a light treatment of the intraocular lens.

CPC Classifications

C08F 220/40 A61F 2/14 C07D 311/16 C07D 405/12 C08F 220/365 G02C 7/049 A61F 2240/001 B29D 11/00009 B29K 2033/12 B29K 2105/0002 B29K 2105/24 C08F 2800/20 C08F 2810/20

Filing Date

2025-10-16

Application No.

19360190

View original document →

Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260109796A1

Who this affects

Applies to
Medical device makers Healthcare providers Manufacturers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent application filing Intraocular device development Refractive correction technology
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!